USE OF TRIPLE ACTIVATOR HAVING ACTIVITY ON ALL OF GLUCAGON, GLP-1 AND GIP RECEPTORS FOR TREATMENT OF SEQUELAE OF RESPIRATORY INFECTIOUS DISEASE

摘要

The present invention relates to use of a triple activator and/or a conjugate thereof to prevent or treat sequelae of respiratory infectious diseases, in which the triple activator and conjugate thereof have activity on all of glucagon, GLP-1 and GIP receptors.